Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Sitemap |
  5. Help
  1. Font size

    Reduce font size Increase font size  
 
 
A rare commitment - Genzyme A Sanofi Company

Contact

Sanofi

Sanofi House
44 on Grand Central Office Park
2 Bond Street
Grand Central Extension 1
Midrand 16

Tel: +27 (0)11 256 3700
Fax: +27 (0)11 847 5099

If your question is related to an emergency, please consult your doctor or emergency unit.

Medical Information and Pharmacovigilance


Content :

Rare Diseases - Genzyme

Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before.

 

Genzyme

Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before.

Genzyme focusses on educating Health Care Professionals regarding the diagnosis, screening and management of the diseases we provide treatment for.

All Genzyme employees are passionate about what they do and are committed to making a significant difference in patients’ lives.

Our objectives are to ensure accurate diagnosis of the diseases we help doctors to treat and to raise awareness of the diseases with doctors, other Health Care Professionals, patient organisations and the public.

Genzyme always endeavours to provide a high standard of service to both treating doctors and their patients. Genzyme's dedication to patients extends beyond the development of products. We've initiated numerous free drug and humanitarian programs to ensure that vital treatment reaches all those who need it.

At Genzyme we recognise the need for patients to have access to ongoing support. We have therefore worked with the South African patient organisation to ensure that patients have people to turn to for help and emotional support. The patient organisation can put them into contact with one another so that they can share their experiences and support each other.

We strive to deliver optimal treatment and reimbursement assistance for the following Lysosomal Storage Disorders: Gaucher, Pompe, MPS 1, MPS 2 & Fabry disease as well a drug that is used to monitor patients with thyroid cancer.

 
pix

Module :

SA Foundation for Rare Disorders
Gaucher Society South Africa
Pedalling4Pompe
World Rare Disease Day 2013
Rare Diseases of South Africa